DISTRIBUTION, ELIMINATION AND EFFECT OF FUROSEMIDE IN NORMAL SUBJECTS AND IN PATIENTS WITH HEART-FAILURE

被引：99

作者：

ANDREASEN, F

MIKKELSEN, E

机构：

[1] UNIV AARHUS,INST PHARMACOL,AARHUS,DENMARK

[2] AARHUS KOMMUNE HOSP,DEPT CARDIOL,AARHUS,DENMARK

来源：

关键词：

D O I：

10.1007/BF00561400

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：15 / 22

页数：8

共 22 条

[1] ANDREASEN F, 1973, ACTA PHARMACOL TOX, V32, P417
[2] ANDREASEN F, 1974, ACTA PHARMACOL TOX, V35, P49
[3] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS
BOXENBAU.HG
RIEGELMA.S
ELASHOFF, RM
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02): : 123 - 148
[4] CALESNICK B, 1966, P SOC EXP BIOL MED, V123, P17
[5] INTRAVENOUS ADMINISTRATION OF FUROSEMIDE IN HEART FAILURE
DAVIDOV, M
KAKAVIAT.N
FINNERTY, FA
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 200 (10): : 824 - &
[6] RENAL AND EXTRARENAL HEMODYNAMIC EFFECTS OF FUROSEMIDE IN CONGESTIVE HEART-FAILURE AFTER ACUTE MYOCARDIAL-INFARCTION
DIKSHIT, K
VYDEN, JK
FORRESTER, JS
CHATTERJEE, K
PRAKASH, R
SWAN, HJC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (21) : 1087 - 1090
[7] DITLEFSEN EML, 1957, ACTA MED SCAND, V159, P105
[8] FOGED L, 1976, ACTA PHARMACOL TOX, V39, P312
[9] FORREY AW, 1974, CLIN CHEM, V20, P152
[10] GIBALDI M, 1972, J PHARM SCI, V61, P952, DOI 10.1002/jps.2600610630